The Institute for Molecular Medicine and Aging is strategically focused on molecular aging pathways, cancer, and drug discovery—areas where our expertise is deep and growing. This sharpened focus enhances our leadership in biomedical research, positioning us to expand funding opportunities and accelerate innovation. We are committed to advancing scientific discovery and developing targeted interventions that promote healthy aging at the molecular level.
